{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:58:10Z","timestamp":1791853090757,"version":"4.3.4"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Naoki Tsuchida Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Clinicians need data on the responsiveness of ileal strictures of Crohn\u2019s disease (CD) to biologic therapy, yet most trials prioritize mucosal healing. We quantified short\u2011term changes in ileal strictures under biologic treatment and evaluated their prognostic relevance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>In a post hoc analysis of a prospective cohort, consecutive patients with ileal or ileocolonic CD initiating or switching a biologic (anti\u2011tumor necrosis factor [TNF], ustekinumab [UST], or vedolizumab [VDZ]) underwent segment\u2011specific endoscopic assessment at baseline and 6\u2009months. The primary outcome was resolution or progression of strictures at 6\u2009months. Secondary outcomes included time\u2011to\u2011event analyses for hospitalization and surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 170 patients, the 6\u2011month stricture resolution and progression rates were 30.9% and 15.7%, respectively. There were no significant differences in stricture dynamics between anti\u2011TNF agents, UST, and VDZ (P\u2009=\u2009.443 for resolution and P\u2009=\u2009.167 for progression). Baseline strictures did not predict outcomes; however, strictures present at 6\u2009months were associated with higher risks of hospitalization (P\u2009=\u2009.006) and surgery (P\u2009=\u2009.024), particularly when located in the non-terminal ileum. Clinical, biochemical, and endoscopic activity improved overall during follow\u2011up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The 6\u2011month stricture status, especially non-terminal ileal disease, carried prognostic significance. Because stricture dynamics did not differ across biologic classes, the presence of strictures alone should not constrain agent selection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izag012","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:28:27Z","timestamp":1768307307000},"page":"1211-1218","source":"Crossref","is-referenced-by-count":1,"title":["Stricture dynamics and prognosis during biologic therapy in ileal Crohn\u2019s disease: a real-world cohort"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7861-8383","authenticated-orcid":false,"given":"Kento","family":"Takenaka","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Institute of Science Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Endoscopic Unit, Institute of Science Tokyo Hospital , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Hibiya","sequence":"additional","affiliation":[{"name":"Endoscopic Unit, Institute of Science Tokyo Hospital , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0917-4095","authenticated-orcid":false,"given":"Akiko","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Institute of Science Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Institute of Science Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Institute of Science Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Institute of Science Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Ohtsuka","sequence":"additional","affiliation":[{"name":"Endoscopic Unit, Institute of Science Tokyo Hospital , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7047-571X","authenticated-orcid":false,"given":"Ryuichi","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Institute of Science Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2026070621112004500_izag012-B1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"2026070621112004500_izag012-B2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/ibd\/izae159","article-title":"Mucosal and transmural healing and long-term outcomes in Crohn\u2019s disease","volume":"31","author":"Sands","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"2026070621112004500_izag012-B3","doi-asserted-by":"publisher","first-page":"e1292","DOI":"10.1016\/j.cgh.2021.08.012","article-title":"Constrictive and hypertrophic strictures in ileal Crohn\u2019s disease","volume":"20","author":"Liu","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026070621112004500_izag012-B4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/ecco-jcc\/jjz158","article-title":"The role of immunomodulators and biologics in the medical management of stricturing Crohn\u2019s disease","volume":"14","author":"Rodr\u00edguez-Lago","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026070621112004500_izag012-B5","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3390\/ijms19082244","article-title":"Anti-TNF therapy in Crohn\u2019s disease","volume":"19","author":"Adegbola","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026070621112004500_izag012-B6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.gie.2014.07.009","article-title":"Magnetic resonance enterography, small-intestine contrast US, and capsule endoscopy to evaluate the small bowel in pediatric Crohn\u2019s disease: a prospective, blinded, comparison study","volume":"81","author":"Aloi","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"2026070621112004500_izag012-B7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1053\/j.gastro.2014.04.008","article-title":"Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn\u2019s disease","volume":"147","author":"Takenaka","year":"2014","journal-title":"Gastroenterology"},{"key":"2026070621112004500_izag012-B8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00535-016-1284-z","article-title":"Magnetic resonance evaluation for small bowel strictures in Crohn\u2019s disease: comparison with balloon enteroscopy","volume":"52","author":"Takenaka","year":"2017","journal-title":"J Gastroenterol"},{"key":"2026070621112004500_izag012-B9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2026070621112004500_izag012-B10","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.cgh.2024.10.030","article-title":"Inadequate efficacy of biologics for treating proximal ileal lesions in Crohn\u2019s disease; a prospective multicenter study","volume":"23","author":"Takenaka","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026070621112004500_izag012-B11","doi-asserted-by":"crossref","first-page":"e1196","DOI":"10.1016\/j.cgh.2021.06.036","article-title":"A novel biomarker for small bowel mucosal activity in Crohn\u2019s disease","volume":"20","author":"Kawamoto","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026070621112004500_izag012-B12","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1097\/MIB.0000000000000449","article-title":"Correlation of the endoscopic and magnetic resonance scoring systems in the deep small intestine in Crohn\u2019s disease","volume":"21","author":"Takenaka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2026070621112004500_izag012-B13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ajg.2017.464","article-title":"Utility of magnetic resonance enterography for small bowel endoscopic healing in patients with Crohn\u2019s disease","volume":"113","author":"Takenaka","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2026070621112004500_izag012-B14","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/den.14429","article-title":"Guidelines for endoscopic balloon dilation in treating Crohn\u2019s disease-associated small intestinal strictures (supplement to the Clinical Practice Guidelines for Enteroscopy)","volume":"34","author":"Yamamoto","year":"2022","journal-title":"Dig Endosc"},{"key":"2026070621112004500_izag012-B15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/ibd\/izx027","article-title":"Capsule endoscopy, magnetic resonance enterography, and small bowel ultrasound for evaluation of postoperative recurrence in Crohn\u2019s disease: systematic review and meta-analysis","volume":"24","author":"Yung","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2026070621112004500_izag012-B16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/ibd\/izx107","article-title":"Comparison of capsule endoscopy and magnetic resonance enterography for the assessment of small bowel lesions in Crohn\u2019s disease","volume":"24","author":"Gonz\u00e1lez-Su\u00e1rez","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2026070621112004500_izag012-B17","doi-asserted-by":"publisher","first-page":"e000365","DOI":"10.1136\/bmjgast-2019-000365","article-title":"Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn\u2019s disease: a multicentre, prospective study","volume":"7","author":"Bruining","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"2026070621112004500_izag012-B18","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.14309\/ajg.0000000000003406","article-title":"IL-23p19 antagonists vs ustekinumab for treatment of Crohn\u2019s disease: a meta-analysis of randomized controlled trials","volume":"120","author":"Dziegielewski","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"2026070621112004500_izag012-B19","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","article-title":"Upadacitinib induction and maintenance therapy for Crohn\u2019s disease","volume":"388","author":"Loftus","year":"2023","journal-title":"N Engl J Med"},{"key":"2026070621112004500_izag012-B20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/gutjnl-2024-332504","article-title":"Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD","volume":"74","author":"Bamias","year":"2025","journal-title":"Gut"},{"key":"2026070621112004500_izag012-B21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/ije\/dyt270","article-title":"Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"43","author":"Hr\u00f3bjartsson","year":"2014","journal-title":"Int J Epidemiol"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/7\/1211\/66843823\/izag012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/7\/1211\/66843823\/izag012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:11:29Z","timestamp":1783386689000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/7\/1211\/8471509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,10]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag012","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,2,10]]}}}